
Director:
|
|
Pathology Consultant:
|
|
Manager:
|
Brittaney L. Brown, BA
|
Staff:
|
Traci Brown, Research Patient Recruiter
Barbara D. Dettore, BSW, Research Study Assistant Mary Donovan, CTR, Senior Data Manager Diane Faison, Scientific Technician II Mary P. Gilroy, AS, Research Study Assistant James Hittle, Technical Specialist Karen Kaputa, MLT/HT, ASCP, Staff Technician/Tumor Bank Manager Alexis Koemm, BS, Scientific Technician II Chao Wu, MS, Technical Specialist |
Location
& Phone: |
|
Pricing & Scheduling:
|
Function
The Biosample Repository Facility (BRF) coordinates the ethical collection, storage, annotation and distribution of human biospecimens and associated clinical data and interventions, patient and family cancer history data, and lifestyle factors under Institutional Review Board-approved protocols. We adhere to the International Society for Biological and Environmental Repositories and National Cancer Institute Best Practices for Biospecimen Resources and participate in the NCI Office of Biorepositories and Biospecimen Resources and Biospecimen Research Network. The BRF expediates bidirectional flow from lab bench to clinic, and facilitates translational research associated with clinical trials and basic research. We provide tissue-based research services—including tissue microarray construction and immunohistochemistry and automated tissue image analysis—to support translational and basic research.
Access to Biospecimens for Research
Fox Chase Cancer Center's Biosample Repository processes and banks blood specimens—including whole blood, plasma, buffy coat, viable cyropreserve leukocytes, and DNA isolated from leukocytes—and tissues—including fresh tissue, snap frozen tissue, fixed paraffin embedded tissue, multi-tissue microarrays and tumor DNAs—collected by our facility and makes them available for research. Requests for blood and tissue specimens are reviewed by a panel of scientists. Priority is given to those investigators with current NIGH/NCI funding, but will be made available as recommended by the facility advisory committee.